Crossmark

Gender and ethnic diversity in randomised clinical trials in age-related macular degeneration and diabetic macular oedema

Published Online: 2025-02-20

Published Print: 2025-05

Authors

Ibrahim, Farah NI

Sivaprasad, Sobha

Cheung, Chui Ming Gemmy https://orcid.org/0000-0003-3358-3516
License Information

Text and Data Mining valid from 2025-02-20

Version of Record valid from 2025-02-20
More Information

Article History

Received: 25 April 2024

Revised: 4 December 2024

Accepted: 7 January 2025

First Online: 20 February 2025

Competing interests

: FNII declares no financial disclosures. SS is a Consultant/Speaker for Novartis, Allergan, and Bayer and a member of the Eye editorial board. CMGC is a Consultant/Speaker for Roche, Bayer, and Boehringer Ingelheim and a member of the Eye editorial board.

Document is current